nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—SLC22A3—prostate cancer	0.177	0.582	CbGaD
Lamivudine—SLC22A1—prostate cancer	0.127	0.418	CbGaD
Lamivudine—ABCC1—Abiraterone—prostate cancer	0.0353	0.0856	CbGbCtD
Lamivudine—ABCC3—Conjugated Estrogens—prostate cancer	0.0272	0.0659	CbGbCtD
Lamivudine—SLC22A3—Estradiol—prostate cancer	0.0224	0.0544	CbGbCtD
Lamivudine—ABCC4—Conjugated Estrogens—prostate cancer	0.0208	0.0504	CbGbCtD
Lamivudine—ABCG2—Cabazitaxel—prostate cancer	0.0175	0.0424	CbGbCtD
Lamivudine—ABCG2—Estrone—prostate cancer	0.0171	0.0414	CbGbCtD
Lamivudine—ABCC2—Ethinyl Estradiol—prostate cancer	0.0168	0.0408	CbGbCtD
Lamivudine—ABCC1—Conjugated Estrogens—prostate cancer	0.0167	0.0405	CbGbCtD
Lamivudine—ABCC3—Etoposide—prostate cancer	0.0156	0.0378	CbGbCtD
Lamivudine—ABCC1—Mitoxantrone—prostate cancer	0.0152	0.0368	CbGbCtD
Lamivudine—SLC22A2—Estradiol—prostate cancer	0.0133	0.0322	CbGbCtD
Lamivudine—ABCC2—Conjugated Estrogens—prostate cancer	0.0123	0.03	CbGbCtD
Lamivudine—ABCC1—Epirubicin—prostate cancer	0.0123	0.0298	CbGbCtD
Lamivudine—SLC22A1—Estradiol—prostate cancer	0.0115	0.028	CbGbCtD
Lamivudine—ABCG2—Conjugated Estrogens—prostate cancer	0.0112	0.0271	CbGbCtD
Lamivudine—ABCC3—Doxorubicin—prostate cancer	0.0106	0.0258	CbGbCtD
Lamivudine—ABCG2—Mitoxantrone—prostate cancer	0.0101	0.0246	CbGbCtD
Lamivudine—ABCG2—Estradiol—prostate cancer	0.0098	0.0238	CbGbCtD
Lamivudine—ABCC1—Etoposide—prostate cancer	0.00956	0.0232	CbGbCtD
Lamivudine—ABCB1—Estramustine—prostate cancer	0.00955	0.0232	CbGbCtD
Lamivudine—SLC22A6—Conjugated Estrogens—prostate cancer	0.00904	0.0219	CbGbCtD
Lamivudine—ABCC1—Docetaxel—prostate cancer	0.00875	0.0212	CbGbCtD
Lamivudine—ABCC2—Etoposide—prostate cancer	0.00708	0.0172	CbGbCtD
Lamivudine—ABCC1—Doxorubicin—prostate cancer	0.00652	0.0158	CbGbCtD
Lamivudine—ABCC2—Docetaxel—prostate cancer	0.00648	0.0157	CbGbCtD
Lamivudine—ABCG2—Etoposide—prostate cancer	0.0064	0.0155	CbGbCtD
Lamivudine—ABCB1—Cabazitaxel—prostate cancer	0.0063	0.0153	CbGbCtD
Lamivudine—ABCB1—Estrone—prostate cancer	0.00615	0.0149	CbGbCtD
Lamivudine—ABCG2—Docetaxel—prostate cancer	0.00586	0.0142	CbGbCtD
Lamivudine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00548	0.0133	CbGbCtD
Lamivudine—ABCC2—Doxorubicin—prostate cancer	0.00483	0.0117	CbGbCtD
Lamivudine—ABCG2—Doxorubicin—prostate cancer	0.00437	0.0106	CbGbCtD
Lamivudine—ABCB1—Conjugated Estrogens—prostate cancer	0.00403	0.00977	CbGbCtD
Lamivudine—ABCB1—Mitoxantrone—prostate cancer	0.00366	0.00888	CbGbCtD
Lamivudine—ABCB1—Estradiol—prostate cancer	0.00353	0.00857	CbGbCtD
Lamivudine—ABCB1—Prednisone—prostate cancer	0.00304	0.00737	CbGbCtD
Lamivudine—NT5C—prostate gland—prostate cancer	0.00272	0.0545	CbGeAlD
Lamivudine—PCYT2—renal system—prostate cancer	0.00255	0.0512	CbGeAlD
Lamivudine—ABCB1—Etoposide—prostate cancer	0.00231	0.0056	CbGbCtD
Lamivudine—ABCB1—Docetaxel—prostate cancer	0.00211	0.00512	CbGbCtD
Lamivudine—NT5C—renal system—prostate cancer	0.00185	0.0372	CbGeAlD
Lamivudine—NT5C—urethra—prostate cancer	0.00182	0.0365	CbGeAlD
Lamivudine—PCYT1A—renal system—prostate cancer	0.00174	0.0349	CbGeAlD
Lamivudine—NME1—prostate gland—prostate cancer	0.0017	0.0342	CbGeAlD
Lamivudine—PCYT2—testis—prostate cancer	0.00165	0.0331	CbGeAlD
Lamivudine—CMPK1—prostate gland—prostate cancer	0.00164	0.033	CbGeAlD
Lamivudine—NME2—prostate gland—prostate cancer	0.00161	0.0322	CbGeAlD
Lamivudine—ABCB1—Doxorubicin—prostate cancer	0.00157	0.00382	CbGbCtD
Lamivudine—PGK1—testis—prostate cancer	0.00142	0.0285	CbGeAlD
Lamivudine—NT5C—testis—prostate cancer	0.0012	0.024	CbGeAlD
Lamivudine—NME2—epithelium—prostate cancer	0.00118	0.0237	CbGeAlD
Lamivudine—NME1—renal system—prostate cancer	0.00116	0.0233	CbGeAlD
Lamivudine—PCYT1A—testis—prostate cancer	0.00112	0.0225	CbGeAlD
Lamivudine—CMPK1—renal system—prostate cancer	0.00112	0.0225	CbGeAlD
Lamivudine—NME2—renal system—prostate cancer	0.00109	0.022	CbGeAlD
Lamivudine—Zalcitabine—CYP3A43—prostate cancer	0.00104	0.363	CrCbGaD
Lamivudine—NME1-NME2—lymph node—prostate cancer	0.000936	0.0188	CbGeAlD
Lamivudine—NME1—bone marrow—prostate cancer	0.000878	0.0176	CbGeAlD
Lamivudine—NT5C—lymph node—prostate cancer	0.000867	0.0174	CbGeAlD
Lamivudine—CMPK1—bone marrow—prostate cancer	0.000846	0.017	CbGeAlD
Lamivudine—DCK—prostate gland—prostate cancer	0.000818	0.0164	CbGeAlD
Lamivudine—Decitabine—DNMT1—prostate cancer	0.000788	0.276	CrCbGaD
Lamivudine—ABCC3—prostate gland—prostate cancer	0.000783	0.0157	CbGeAlD
Lamivudine—NME1—testis—prostate cancer	0.000751	0.0151	CbGeAlD
Lamivudine—CMPK1—testis—prostate cancer	0.000724	0.0145	CbGeAlD
Lamivudine—NME2—testis—prostate cancer	0.000707	0.0142	CbGeAlD
Lamivudine—DCK—seminal vesicle—prostate cancer	0.000692	0.0139	CbGeAlD
Lamivudine—SLC22A2—renal system—prostate cancer	0.000673	0.0135	CbGeAlD
Lamivudine—SLC22A3—prostate gland—prostate cancer	0.000667	0.0134	CbGeAlD
Lamivudine—ABCC4—prostate gland—prostate cancer	0.000646	0.013	CbGeAlD
Lamivudine—ABCC2—prostate gland—prostate cancer	0.000626	0.0126	CbGeAlD
Lamivudine—SLC22A3—seminal vesicle—prostate cancer	0.000564	0.0113	CbGeAlD
Lamivudine—ABCC1—prostate gland—prostate cancer	0.000551	0.0111	CbGeAlD
Lamivudine—DCK—urethra—prostate cancer	0.000548	0.011	CbGeAlD
Lamivudine—NME1—lymph node—prostate cancer	0.000544	0.0109	CbGeAlD
Lamivudine—ABCC3—renal system—prostate cancer	0.000534	0.0107	CbGeAlD
Lamivudine—CMPK1—lymph node—prostate cancer	0.000525	0.0105	CbGeAlD
Lamivudine—NME2—lymph node—prostate cancer	0.000513	0.0103	CbGeAlD
Lamivudine—SLC22A1—renal system—prostate cancer	0.000475	0.00955	CbGeAlD
Lamivudine—ABCC1—seminal vesicle—prostate cancer	0.000466	0.00936	CbGeAlD
Lamivudine—ABCG2—prostate gland—prostate cancer	0.000456	0.00916	CbGeAlD
Lamivudine—SLC22A3—renal system—prostate cancer	0.000454	0.00912	CbGeAlD
Lamivudine—SLC22A3—urethra—prostate cancer	0.000446	0.00896	CbGeAlD
Lamivudine—ABCC4—renal system—prostate cancer	0.000441	0.00885	CbGeAlD
Lamivudine—ABCC2—renal system—prostate cancer	0.000426	0.00856	CbGeAlD
Lamivudine—DCK—bone marrow—prostate cancer	0.000421	0.00846	CbGeAlD
Lamivudine—ABCG2—seminal vesicle—prostate cancer	0.000386	0.00775	CbGeAlD
Lamivudine—ABCC1—urethra—prostate cancer	0.000369	0.00741	CbGeAlD
Lamivudine—Gemcitabine—TYMS—prostate cancer	0.000363	0.127	CrCbGaD
Lamivudine—DCK—testis—prostate cancer	0.00036	0.00723	CbGeAlD
Lamivudine—ABCC3—testis—prostate cancer	0.000345	0.00693	CbGeAlD
Lamivudine—DCK—Estradiol valerate/Dienogest—Estrone—prostate cancer	0.000339	0.162	CbGdCrCtD
Lamivudine—ABCC4—bone marrow—prostate cancer	0.000333	0.00669	CbGeAlD
Lamivudine—ABCG2—urethra—prostate cancer	0.000305	0.00613	CbGeAlD
Lamivudine—SLC22A3—testis—prostate cancer	0.000294	0.0059	CbGeAlD
Lamivudine—ABCC4—testis—prostate cancer	0.000285	0.00572	CbGeAlD
Lamivudine—ABCC2—testis—prostate cancer	0.000276	0.00553	CbGeAlD
Lamivudine—DCK—Fulvestrant—Estradiol—prostate cancer	0.000274	0.131	CbGdCrCtD
Lamivudine—DCK—lymph node—prostate cancer	0.000261	0.00524	CbGeAlD
Lamivudine—Zalcitabine—CYP3A5—prostate cancer	0.00026	0.0911	CrCbGaD
Lamivudine—DCK—Estradiol valerate/Dienogest—Estradiol—prostate cancer	0.000257	0.123	CbGdCrCtD
Lamivudine—DCK—Estradiol valerate/Dienogest—Ethinyl Estradiol—prostate cancer	0.00025	0.12	CbGdCrCtD
Lamivudine—ABCC3—lymph node—prostate cancer	0.00025	0.00502	CbGeAlD
Lamivudine—ABCC1—testis—prostate cancer	0.000243	0.00487	CbGeAlD
Lamivudine—DCK—Levorphanol—Estrone—prostate cancer	0.000239	0.114	CbGdCrCtD
Lamivudine—ABCG2—bone marrow—prostate cancer	0.000235	0.00472	CbGeAlD
Lamivudine—ABCB1—prostate gland—prostate cancer	0.000225	0.00452	CbGeAlD
Lamivudine—Cytarabine—SLC22A1—prostate cancer	0.000216	0.0758	CrCbGaD
Lamivudine—SLC22A3—lymph node—prostate cancer	0.000213	0.00427	CbGeAlD
Lamivudine—ABCC4—lymph node—prostate cancer	0.000206	0.00414	CbGeAlD
Lamivudine—ABCG2—testis—prostate cancer	0.000201	0.00404	CbGeAlD
Lamivudine—ABCC2—lymph node—prostate cancer	0.0002	0.00401	CbGeAlD
Lamivudine—ABCB1—seminal vesicle—prostate cancer	0.00019	0.00382	CbGeAlD
Lamivudine—DCK—Levorphanol—Estradiol—prostate cancer	0.000181	0.0864	CbGdCrCtD
Lamivudine—ABCC1—lymph node—prostate cancer	0.000176	0.00353	CbGeAlD
Lamivudine—ABCB1—epithelium—prostate cancer	0.000165	0.00332	CbGeAlD
Lamivudine—ABCB1—renal system—prostate cancer	0.000153	0.00308	CbGeAlD
Lamivudine—ABCB1—urethra—prostate cancer	0.000151	0.00302	CbGeAlD
Lamivudine—ABCG2—lymph node—prostate cancer	0.000146	0.00293	CbGeAlD
Lamivudine—NME1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000126	0.0601	CbGdCrCtD
Lamivudine—DCK—Doxorubicin—Epirubicin—prostate cancer	0.000126	0.06	CbGdCrCtD
Lamivudine—DCK—Epirubicin—Doxorubicin—prostate cancer	0.000116	0.0555	CbGdCrCtD
Lamivudine—ABCB1—bone marrow—prostate cancer	0.000116	0.00233	CbGeAlD
Lamivudine—Zalcitabine—CYP3A4—prostate cancer	0.000112	0.0394	CrCbGaD
Lamivudine—ABCB1—testis—prostate cancer	9.91e-05	0.00199	CbGeAlD
Lamivudine—DCK—Levonorgestrel—Ethinyl Estradiol—prostate cancer	8.57e-05	0.0409	CbGdCrCtD
Lamivudine—Cytarabine—CYP3A4—prostate cancer	7.54e-05	0.0265	CrCbGaD
Lamivudine—ABCB1—lymph node—prostate cancer	7.18e-05	0.00144	CbGeAlD
Lamivudine—DCK—Desoximetasone—Prednisone—prostate cancer	5.15e-05	0.0246	CbGdCrCtD
Lamivudine—DCK—Diflorasone—Prednisone—prostate cancer	5e-05	0.0239	CbGdCrCtD
Lamivudine—Sweating—Doxorubicin—prostate cancer	3.1e-05	0.000238	CcSEcCtD
Lamivudine—Hyperhidrosis—Capecitabine—prostate cancer	3.09e-05	0.000237	CcSEcCtD
Lamivudine—Hypotension—Docetaxel—prostate cancer	3.09e-05	0.000237	CcSEcCtD
Lamivudine—Connective tissue disorder—Epirubicin—prostate cancer	3.08e-05	0.000237	CcSEcCtD
Lamivudine—Loss of consciousness—Prednisone—prostate cancer	3.07e-05	0.000236	CcSEcCtD
Lamivudine—Hepatobiliary disease—Doxorubicin—prostate cancer	3.06e-05	0.000235	CcSEcCtD
Lamivudine—Epistaxis—Doxorubicin—prostate cancer	3.05e-05	0.000234	CcSEcCtD
Lamivudine—Anorexia—Capecitabine—prostate cancer	3.05e-05	0.000234	CcSEcCtD
Lamivudine—Nausea—Estradiol—prostate cancer	3.05e-05	0.000234	CcSEcCtD
Lamivudine—Vomiting—Mitoxantrone—prostate cancer	3.04e-05	0.000233	CcSEcCtD
Lamivudine—Sinusitis—Doxorubicin—prostate cancer	3.03e-05	0.000233	CcSEcCtD
Lamivudine—Convulsion—Prednisone—prostate cancer	3.03e-05	0.000232	CcSEcCtD
Lamivudine—Agranulocytosis—Doxorubicin—prostate cancer	3.02e-05	0.000232	CcSEcCtD
Lamivudine—Rash—Mitoxantrone—prostate cancer	3.01e-05	0.000231	CcSEcCtD
Lamivudine—Dermatitis—Mitoxantrone—prostate cancer	3.01e-05	0.000231	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.01e-05	0.000231	CcSEcCtD
Lamivudine—Headache—Mitoxantrone—prostate cancer	3e-05	0.00023	CcSEcCtD
Lamivudine—Hypotension—Capecitabine—prostate cancer	2.99e-05	0.000229	CcSEcCtD
Lamivudine—Insomnia—Docetaxel—prostate cancer	2.99e-05	0.000229	CcSEcCtD
Lamivudine—Myalgia—Prednisone—prostate cancer	2.97e-05	0.000228	CcSEcCtD
Lamivudine—Arthralgia—Prednisone—prostate cancer	2.97e-05	0.000228	CcSEcCtD
Lamivudine—Paraesthesia—Docetaxel—prostate cancer	2.97e-05	0.000228	CcSEcCtD
Lamivudine—Erythema multiforme—Epirubicin—prostate cancer	2.97e-05	0.000228	CcSEcCtD
Lamivudine—Anxiety—Prednisone—prostate cancer	2.96e-05	0.000227	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	2.95e-05	0.000227	CcSEcCtD
Lamivudine—Dyspnoea—Docetaxel—prostate cancer	2.95e-05	0.000226	CcSEcCtD
Lamivudine—Somnolence—Docetaxel—prostate cancer	2.94e-05	0.000225	CcSEcCtD
Lamivudine—Discomfort—Prednisone—prostate cancer	2.94e-05	0.000225	CcSEcCtD
Lamivudine—Hypersensitivity—Etoposide—prostate cancer	2.93e-05	0.000225	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.92e-05	0.000224	CcSEcCtD
Lamivudine—Rhinitis—Doxorubicin—prostate cancer	2.91e-05	0.000223	CcSEcCtD
Lamivudine—Dyspepsia—Docetaxel—prostate cancer	2.91e-05	0.000223	CcSEcCtD
Lamivudine—Hepatitis—Doxorubicin—prostate cancer	2.9e-05	0.000223	CcSEcCtD
Lamivudine—Insomnia—Capecitabine—prostate cancer	2.89e-05	0.000222	CcSEcCtD
Lamivudine—Hypoaesthesia—Doxorubicin—prostate cancer	2.89e-05	0.000222	CcSEcCtD
Lamivudine—Pharyngitis—Doxorubicin—prostate cancer	2.88e-05	0.000221	CcSEcCtD
Lamivudine—Paraesthesia—Capecitabine—prostate cancer	2.87e-05	0.00022	CcSEcCtD
Lamivudine—Decreased appetite—Docetaxel—prostate cancer	2.87e-05	0.00022	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Docetaxel—prostate cancer	2.85e-05	0.000219	CcSEcCtD
Lamivudine—Asthenia—Etoposide—prostate cancer	2.85e-05	0.000219	CcSEcCtD
Lamivudine—Connective tissue disorder—Doxorubicin—prostate cancer	2.85e-05	0.000219	CcSEcCtD
Lamivudine—Dyspnoea—Capecitabine—prostate cancer	2.85e-05	0.000219	CcSEcCtD
Lamivudine—Oedema—Prednisone—prostate cancer	2.85e-05	0.000219	CcSEcCtD
Lamivudine—Anaphylactic shock—Prednisone—prostate cancer	2.85e-05	0.000219	CcSEcCtD
Lamivudine—Fatigue—Docetaxel—prostate cancer	2.85e-05	0.000219	CcSEcCtD
Lamivudine—Nausea—Mitoxantrone—prostate cancer	2.84e-05	0.000218	CcSEcCtD
Lamivudine—Immune system disorder—Epirubicin—prostate cancer	2.83e-05	0.000217	CcSEcCtD
Lamivudine—Infection—Prednisone—prostate cancer	2.83e-05	0.000217	CcSEcCtD
Lamivudine—Mediastinal disorder—Epirubicin—prostate cancer	2.83e-05	0.000217	CcSEcCtD
Lamivudine—Pain—Docetaxel—prostate cancer	2.83e-05	0.000217	CcSEcCtD
Lamivudine—Constipation—Docetaxel—prostate cancer	2.83e-05	0.000217	CcSEcCtD
Lamivudine—Dyspepsia—Capecitabine—prostate cancer	2.82e-05	0.000216	CcSEcCtD
Lamivudine—Chills—Epirubicin—prostate cancer	2.82e-05	0.000216	CcSEcCtD
Lamivudine—Pruritus—Etoposide—prostate cancer	2.81e-05	0.000216	CcSEcCtD
Lamivudine—Shock—Prednisone—prostate cancer	2.8e-05	0.000215	CcSEcCtD
Lamivudine—Nervous system disorder—Prednisone—prostate cancer	2.8e-05	0.000214	CcSEcCtD
Lamivudine—Decreased appetite—Capecitabine—prostate cancer	2.78e-05	0.000213	CcSEcCtD
Lamivudine—Alopecia—Epirubicin—prostate cancer	2.77e-05	0.000213	CcSEcCtD
Lamivudine—Skin disorder—Prednisone—prostate cancer	2.77e-05	0.000212	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Capecitabine—prostate cancer	2.76e-05	0.000212	CcSEcCtD
Lamivudine—Fatigue—Capecitabine—prostate cancer	2.76e-05	0.000212	CcSEcCtD
Lamivudine—Hyperhidrosis—Prednisone—prostate cancer	2.76e-05	0.000211	CcSEcCtD
Lamivudine—Erythema multiforme—Doxorubicin—prostate cancer	2.75e-05	0.000211	CcSEcCtD
Lamivudine—Constipation—Capecitabine—prostate cancer	2.74e-05	0.00021	CcSEcCtD
Lamivudine—Pain—Capecitabine—prostate cancer	2.74e-05	0.00021	CcSEcCtD
Lamivudine—Erythema—Epirubicin—prostate cancer	2.73e-05	0.00021	CcSEcCtD
Lamivudine—Malnutrition—Epirubicin—prostate cancer	2.73e-05	0.00021	CcSEcCtD
Lamivudine—Feeling abnormal—Docetaxel—prostate cancer	2.72e-05	0.000209	CcSEcCtD
Lamivudine—Diarrhoea—Etoposide—prostate cancer	2.72e-05	0.000209	CcSEcCtD
Lamivudine—Anorexia—Prednisone—prostate cancer	2.72e-05	0.000208	CcSEcCtD
Lamivudine—Gastrointestinal pain—Docetaxel—prostate cancer	2.7e-05	0.000207	CcSEcCtD
Lamivudine—Flatulence—Epirubicin—prostate cancer	2.69e-05	0.000207	CcSEcCtD
Lamivudine—Tension—Epirubicin—prostate cancer	2.68e-05	0.000206	CcSEcCtD
Lamivudine—Dysgeusia—Epirubicin—prostate cancer	2.68e-05	0.000205	CcSEcCtD
Lamivudine—Nervousness—Epirubicin—prostate cancer	2.65e-05	0.000204	CcSEcCtD
Lamivudine—Back pain—Epirubicin—prostate cancer	2.64e-05	0.000203	CcSEcCtD
Lamivudine—Feeling abnormal—Capecitabine—prostate cancer	2.64e-05	0.000202	CcSEcCtD
Lamivudine—Dizziness—Etoposide—prostate cancer	2.63e-05	0.000202	CcSEcCtD
Lamivudine—Muscle spasms—Epirubicin—prostate cancer	2.63e-05	0.000201	CcSEcCtD
Lamivudine—Immune system disorder—Doxorubicin—prostate cancer	2.62e-05	0.000201	CcSEcCtD
Lamivudine—Gastrointestinal pain—Capecitabine—prostate cancer	2.62e-05	0.000201	CcSEcCtD
Lamivudine—Mediastinal disorder—Doxorubicin—prostate cancer	2.62e-05	0.000201	CcSEcCtD
Lamivudine—Body temperature increased—Docetaxel—prostate cancer	2.61e-05	0.0002	CcSEcCtD
Lamivudine—Abdominal pain—Docetaxel—prostate cancer	2.61e-05	0.0002	CcSEcCtD
Lamivudine—Chills—Doxorubicin—prostate cancer	2.61e-05	0.0002	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Prednisone—prostate cancer	2.6e-05	0.000199	CcSEcCtD
Lamivudine—Insomnia—Prednisone—prostate cancer	2.58e-05	0.000198	CcSEcCtD
Lamivudine—Alopecia—Doxorubicin—prostate cancer	2.57e-05	0.000197	CcSEcCtD
Lamivudine—Paraesthesia—Prednisone—prostate cancer	2.56e-05	0.000196	CcSEcCtD
Lamivudine—Urticaria—Capecitabine—prostate cancer	2.54e-05	0.000195	CcSEcCtD
Lamivudine—Ill-defined disorder—Epirubicin—prostate cancer	2.53e-05	0.000194	CcSEcCtD
Lamivudine—Abdominal pain—Capecitabine—prostate cancer	2.53e-05	0.000194	CcSEcCtD
Lamivudine—Body temperature increased—Capecitabine—prostate cancer	2.53e-05	0.000194	CcSEcCtD
Lamivudine—Vomiting—Etoposide—prostate cancer	2.53e-05	0.000194	CcSEcCtD
Lamivudine—Malnutrition—Doxorubicin—prostate cancer	2.53e-05	0.000194	CcSEcCtD
Lamivudine—Erythema—Doxorubicin—prostate cancer	2.53e-05	0.000194	CcSEcCtD
Lamivudine—Anaemia—Epirubicin—prostate cancer	2.52e-05	0.000194	CcSEcCtD
Lamivudine—Dyspepsia—Prednisone—prostate cancer	2.51e-05	0.000193	CcSEcCtD
Lamivudine—Rash—Etoposide—prostate cancer	2.51e-05	0.000192	CcSEcCtD
Lamivudine—Dermatitis—Etoposide—prostate cancer	2.51e-05	0.000192	CcSEcCtD
Lamivudine—Headache—Etoposide—prostate cancer	2.49e-05	0.000191	CcSEcCtD
Lamivudine—Flatulence—Doxorubicin—prostate cancer	2.49e-05	0.000191	CcSEcCtD
Lamivudine—Tension—Doxorubicin—prostate cancer	2.48e-05	0.00019	CcSEcCtD
Lamivudine—Decreased appetite—Prednisone—prostate cancer	2.48e-05	0.00019	CcSEcCtD
Lamivudine—Dysgeusia—Doxorubicin—prostate cancer	2.48e-05	0.00019	CcSEcCtD
Lamivudine—Malaise—Epirubicin—prostate cancer	2.46e-05	0.000189	CcSEcCtD
Lamivudine—Fatigue—Prednisone—prostate cancer	2.46e-05	0.000189	CcSEcCtD
Lamivudine—Nervousness—Doxorubicin—prostate cancer	2.45e-05	0.000188	CcSEcCtD
Lamivudine—Vertigo—Epirubicin—prostate cancer	2.45e-05	0.000188	CcSEcCtD
Lamivudine—Syncope—Epirubicin—prostate cancer	2.45e-05	0.000188	CcSEcCtD
Lamivudine—Leukopenia—Epirubicin—prostate cancer	2.45e-05	0.000188	CcSEcCtD
Lamivudine—Back pain—Doxorubicin—prostate cancer	2.44e-05	0.000188	CcSEcCtD
Lamivudine—Constipation—Prednisone—prostate cancer	2.44e-05	0.000187	CcSEcCtD
Lamivudine—Hypersensitivity—Docetaxel—prostate cancer	2.44e-05	0.000187	CcSEcCtD
Lamivudine—Muscle spasms—Doxorubicin—prostate cancer	2.43e-05	0.000186	CcSEcCtD
Lamivudine—Loss of consciousness—Epirubicin—prostate cancer	2.4e-05	0.000184	CcSEcCtD
Lamivudine—Cough—Epirubicin—prostate cancer	2.38e-05	0.000183	CcSEcCtD
Lamivudine—Asthenia—Docetaxel—prostate cancer	2.37e-05	0.000182	CcSEcCtD
Lamivudine—Convulsion—Epirubicin—prostate cancer	2.37e-05	0.000182	CcSEcCtD
Lamivudine—Nausea—Etoposide—prostate cancer	2.36e-05	0.000181	CcSEcCtD
Lamivudine—Hypersensitivity—Capecitabine—prostate cancer	2.36e-05	0.000181	CcSEcCtD
Lamivudine—Feeling abnormal—Prednisone—prostate cancer	2.35e-05	0.00018	CcSEcCtD
Lamivudine—Ill-defined disorder—Doxorubicin—prostate cancer	2.35e-05	0.00018	CcSEcCtD
Lamivudine—Pruritus—Docetaxel—prostate cancer	2.34e-05	0.000179	CcSEcCtD
Lamivudine—Anaemia—Doxorubicin—prostate cancer	2.34e-05	0.000179	CcSEcCtD
Lamivudine—Gastrointestinal pain—Prednisone—prostate cancer	2.33e-05	0.000179	CcSEcCtD
Lamivudine—Arthralgia—Epirubicin—prostate cancer	2.33e-05	0.000178	CcSEcCtD
Lamivudine—Myalgia—Epirubicin—prostate cancer	2.33e-05	0.000178	CcSEcCtD
Lamivudine—Chest pain—Epirubicin—prostate cancer	2.33e-05	0.000178	CcSEcCtD
Lamivudine—Anxiety—Epirubicin—prostate cancer	2.32e-05	0.000178	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.31e-05	0.000177	CcSEcCtD
Lamivudine—Discomfort—Epirubicin—prostate cancer	2.3e-05	0.000176	CcSEcCtD
Lamivudine—Asthenia—Capecitabine—prostate cancer	2.3e-05	0.000176	CcSEcCtD
Lamivudine—Malaise—Doxorubicin—prostate cancer	2.28e-05	0.000175	CcSEcCtD
Lamivudine—Dry mouth—Epirubicin—prostate cancer	2.27e-05	0.000174	CcSEcCtD
Lamivudine—Vertigo—Doxorubicin—prostate cancer	2.27e-05	0.000174	CcSEcCtD
Lamivudine—Syncope—Doxorubicin—prostate cancer	2.27e-05	0.000174	CcSEcCtD
Lamivudine—Urticaria—Prednisone—prostate cancer	2.26e-05	0.000174	CcSEcCtD
Lamivudine—Pruritus—Capecitabine—prostate cancer	2.26e-05	0.000174	CcSEcCtD
Lamivudine—Leukopenia—Doxorubicin—prostate cancer	2.26e-05	0.000174	CcSEcCtD
Lamivudine—Diarrhoea—Docetaxel—prostate cancer	2.26e-05	0.000174	CcSEcCtD
Lamivudine—Abdominal pain—Prednisone—prostate cancer	2.25e-05	0.000173	CcSEcCtD
Lamivudine—Body temperature increased—Prednisone—prostate cancer	2.25e-05	0.000173	CcSEcCtD
Lamivudine—Confusional state—Epirubicin—prostate cancer	2.25e-05	0.000172	CcSEcCtD
Lamivudine—Oedema—Epirubicin—prostate cancer	2.23e-05	0.000171	CcSEcCtD
Lamivudine—Anaphylactic shock—Epirubicin—prostate cancer	2.23e-05	0.000171	CcSEcCtD
Lamivudine—Loss of consciousness—Doxorubicin—prostate cancer	2.22e-05	0.00017	CcSEcCtD
Lamivudine—Infection—Epirubicin—prostate cancer	2.21e-05	0.00017	CcSEcCtD
Lamivudine—Cough—Doxorubicin—prostate cancer	2.21e-05	0.000169	CcSEcCtD
Lamivudine—Shock—Epirubicin—prostate cancer	2.19e-05	0.000168	CcSEcCtD
Lamivudine—Convulsion—Doxorubicin—prostate cancer	2.19e-05	0.000168	CcSEcCtD
Lamivudine—Diarrhoea—Capecitabine—prostate cancer	2.19e-05	0.000168	CcSEcCtD
Lamivudine—Nervous system disorder—Epirubicin—prostate cancer	2.19e-05	0.000168	CcSEcCtD
Lamivudine—Dizziness—Docetaxel—prostate cancer	2.19e-05	0.000168	CcSEcCtD
Lamivudine—Thrombocytopenia—Epirubicin—prostate cancer	2.18e-05	0.000167	CcSEcCtD
Lamivudine—Skin disorder—Epirubicin—prostate cancer	2.17e-05	0.000166	CcSEcCtD
Lamivudine—Hyperhidrosis—Epirubicin—prostate cancer	2.16e-05	0.000165	CcSEcCtD
Lamivudine—Myalgia—Doxorubicin—prostate cancer	2.15e-05	0.000165	CcSEcCtD
Lamivudine—Chest pain—Doxorubicin—prostate cancer	2.15e-05	0.000165	CcSEcCtD
Lamivudine—Arthralgia—Doxorubicin—prostate cancer	2.15e-05	0.000165	CcSEcCtD
Lamivudine—Anxiety—Doxorubicin—prostate cancer	2.14e-05	0.000165	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.14e-05	0.000164	CcSEcCtD
Lamivudine—Discomfort—Doxorubicin—prostate cancer	2.13e-05	0.000163	CcSEcCtD
Lamivudine—Anorexia—Epirubicin—prostate cancer	2.13e-05	0.000163	CcSEcCtD
Lamivudine—Dizziness—Capecitabine—prostate cancer	2.12e-05	0.000162	CcSEcCtD
Lamivudine—Dry mouth—Doxorubicin—prostate cancer	2.1e-05	0.000161	CcSEcCtD
Lamivudine—Vomiting—Docetaxel—prostate cancer	2.1e-05	0.000161	CcSEcCtD
Lamivudine—Hypersensitivity—Prednisone—prostate cancer	2.1e-05	0.000161	CcSEcCtD
Lamivudine—Rash—Docetaxel—prostate cancer	2.08e-05	0.00016	CcSEcCtD
Lamivudine—Hypotension—Epirubicin—prostate cancer	2.08e-05	0.00016	CcSEcCtD
Lamivudine—Dermatitis—Docetaxel—prostate cancer	2.08e-05	0.00016	CcSEcCtD
Lamivudine—Confusional state—Doxorubicin—prostate cancer	2.08e-05	0.00016	CcSEcCtD
Lamivudine—Headache—Docetaxel—prostate cancer	2.07e-05	0.000159	CcSEcCtD
Lamivudine—Anaphylactic shock—Doxorubicin—prostate cancer	2.06e-05	0.000158	CcSEcCtD
Lamivudine—Oedema—Doxorubicin—prostate cancer	2.06e-05	0.000158	CcSEcCtD
Lamivudine—Infection—Doxorubicin—prostate cancer	2.05e-05	0.000157	CcSEcCtD
Lamivudine—Asthenia—Prednisone—prostate cancer	2.05e-05	0.000157	CcSEcCtD
Lamivudine—Vomiting—Capecitabine—prostate cancer	2.03e-05	0.000156	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.03e-05	0.000156	CcSEcCtD
Lamivudine—Shock—Doxorubicin—prostate cancer	2.03e-05	0.000156	CcSEcCtD
Lamivudine—Nervous system disorder—Doxorubicin—prostate cancer	2.02e-05	0.000155	CcSEcCtD
Lamivudine—Thrombocytopenia—Doxorubicin—prostate cancer	2.02e-05	0.000155	CcSEcCtD
Lamivudine—Rash—Capecitabine—prostate cancer	2.02e-05	0.000155	CcSEcCtD
Lamivudine—Pruritus—Prednisone—prostate cancer	2.02e-05	0.000155	CcSEcCtD
Lamivudine—Insomnia—Epirubicin—prostate cancer	2.02e-05	0.000155	CcSEcCtD
Lamivudine—Dermatitis—Capecitabine—prostate cancer	2.02e-05	0.000155	CcSEcCtD
Lamivudine—Headache—Capecitabine—prostate cancer	2e-05	0.000154	CcSEcCtD
Lamivudine—Skin disorder—Doxorubicin—prostate cancer	2e-05	0.000154	CcSEcCtD
Lamivudine—Paraesthesia—Epirubicin—prostate cancer	2e-05	0.000154	CcSEcCtD
Lamivudine—Hyperhidrosis—Doxorubicin—prostate cancer	1.99e-05	0.000153	CcSEcCtD
Lamivudine—Dyspnoea—Epirubicin—prostate cancer	1.99e-05	0.000152	CcSEcCtD
Lamivudine—Somnolence—Epirubicin—prostate cancer	1.98e-05	0.000152	CcSEcCtD
Lamivudine—Anorexia—Doxorubicin—prostate cancer	1.97e-05	0.000151	CcSEcCtD
Lamivudine—Nausea—Docetaxel—prostate cancer	1.96e-05	0.000151	CcSEcCtD
Lamivudine—Dyspepsia—Epirubicin—prostate cancer	1.96e-05	0.000151	CcSEcCtD
Lamivudine—Diarrhoea—Prednisone—prostate cancer	1.95e-05	0.00015	CcSEcCtD
Lamivudine—Decreased appetite—Epirubicin—prostate cancer	1.94e-05	0.000149	CcSEcCtD
Lamivudine—Hypotension—Doxorubicin—prostate cancer	1.93e-05	0.000148	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Epirubicin—prostate cancer	1.92e-05	0.000148	CcSEcCtD
Lamivudine—Fatigue—Epirubicin—prostate cancer	1.92e-05	0.000147	CcSEcCtD
Lamivudine—Pain—Epirubicin—prostate cancer	1.91e-05	0.000146	CcSEcCtD
Lamivudine—Constipation—Epirubicin—prostate cancer	1.91e-05	0.000146	CcSEcCtD
Lamivudine—Nausea—Capecitabine—prostate cancer	1.9e-05	0.000146	CcSEcCtD
Lamivudine—Dizziness—Prednisone—prostate cancer	1.89e-05	0.000145	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.88e-05	0.000144	CcSEcCtD
Lamivudine—Insomnia—Doxorubicin—prostate cancer	1.87e-05	0.000143	CcSEcCtD
Lamivudine—Paraesthesia—Doxorubicin—prostate cancer	1.85e-05	0.000142	CcSEcCtD
Lamivudine—Dyspnoea—Doxorubicin—prostate cancer	1.84e-05	0.000141	CcSEcCtD
Lamivudine—Feeling abnormal—Epirubicin—prostate cancer	1.84e-05	0.000141	CcSEcCtD
Lamivudine—Somnolence—Doxorubicin—prostate cancer	1.83e-05	0.000141	CcSEcCtD
Lamivudine—Gastrointestinal pain—Epirubicin—prostate cancer	1.82e-05	0.00014	CcSEcCtD
Lamivudine—Dyspepsia—Doxorubicin—prostate cancer	1.82e-05	0.000139	CcSEcCtD
Lamivudine—Vomiting—Prednisone—prostate cancer	1.81e-05	0.000139	CcSEcCtD
Lamivudine—Rash—Prednisone—prostate cancer	1.8e-05	0.000138	CcSEcCtD
Lamivudine—Dermatitis—Prednisone—prostate cancer	1.8e-05	0.000138	CcSEcCtD
Lamivudine—Decreased appetite—Doxorubicin—prostate cancer	1.79e-05	0.000138	CcSEcCtD
Lamivudine—Headache—Prednisone—prostate cancer	1.79e-05	0.000137	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.78e-05	0.000137	CcSEcCtD
Lamivudine—Fatigue—Doxorubicin—prostate cancer	1.78e-05	0.000136	CcSEcCtD
Lamivudine—Urticaria—Epirubicin—prostate cancer	1.77e-05	0.000136	CcSEcCtD
Lamivudine—Pain—Doxorubicin—prostate cancer	1.76e-05	0.000135	CcSEcCtD
Lamivudine—Constipation—Doxorubicin—prostate cancer	1.76e-05	0.000135	CcSEcCtD
Lamivudine—Body temperature increased—Epirubicin—prostate cancer	1.76e-05	0.000135	CcSEcCtD
Lamivudine—Abdominal pain—Epirubicin—prostate cancer	1.76e-05	0.000135	CcSEcCtD
Lamivudine—Feeling abnormal—Doxorubicin—prostate cancer	1.7e-05	0.00013	CcSEcCtD
Lamivudine—Nausea—Prednisone—prostate cancer	1.69e-05	0.00013	CcSEcCtD
Lamivudine—Gastrointestinal pain—Doxorubicin—prostate cancer	1.69e-05	0.000129	CcSEcCtD
Lamivudine—Hypersensitivity—Epirubicin—prostate cancer	1.64e-05	0.000126	CcSEcCtD
Lamivudine—Urticaria—Doxorubicin—prostate cancer	1.64e-05	0.000126	CcSEcCtD
Lamivudine—Body temperature increased—Doxorubicin—prostate cancer	1.63e-05	0.000125	CcSEcCtD
Lamivudine—Abdominal pain—Doxorubicin—prostate cancer	1.63e-05	0.000125	CcSEcCtD
Lamivudine—Asthenia—Epirubicin—prostate cancer	1.6e-05	0.000123	CcSEcCtD
Lamivudine—Pruritus—Epirubicin—prostate cancer	1.58e-05	0.000121	CcSEcCtD
Lamivudine—Diarrhoea—Epirubicin—prostate cancer	1.53e-05	0.000117	CcSEcCtD
Lamivudine—Hypersensitivity—Doxorubicin—prostate cancer	1.52e-05	0.000117	CcSEcCtD
Lamivudine—Asthenia—Doxorubicin—prostate cancer	1.48e-05	0.000114	CcSEcCtD
Lamivudine—Dizziness—Epirubicin—prostate cancer	1.47e-05	0.000113	CcSEcCtD
Lamivudine—Pruritus—Doxorubicin—prostate cancer	1.46e-05	0.000112	CcSEcCtD
Lamivudine—Vomiting—Epirubicin—prostate cancer	1.42e-05	0.000109	CcSEcCtD
Lamivudine—Diarrhoea—Doxorubicin—prostate cancer	1.41e-05	0.000108	CcSEcCtD
Lamivudine—Rash—Epirubicin—prostate cancer	1.41e-05	0.000108	CcSEcCtD
Lamivudine—Dermatitis—Epirubicin—prostate cancer	1.4e-05	0.000108	CcSEcCtD
Lamivudine—Headache—Epirubicin—prostate cancer	1.4e-05	0.000107	CcSEcCtD
Lamivudine—Dizziness—Doxorubicin—prostate cancer	1.36e-05	0.000105	CcSEcCtD
Lamivudine—Nausea—Epirubicin—prostate cancer	1.32e-05	0.000102	CcSEcCtD
Lamivudine—Vomiting—Doxorubicin—prostate cancer	1.31e-05	0.000101	CcSEcCtD
Lamivudine—Rash—Doxorubicin—prostate cancer	1.3e-05	9.98e-05	CcSEcCtD
Lamivudine—Dermatitis—Doxorubicin—prostate cancer	1.3e-05	9.97e-05	CcSEcCtD
Lamivudine—Headache—Doxorubicin—prostate cancer	1.29e-05	9.91e-05	CcSEcCtD
Lamivudine—Nausea—Doxorubicin—prostate cancer	1.23e-05	9.4e-05	CcSEcCtD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.91e-06	2.92e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP1B1—prostate cancer	2.9e-06	2.91e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB3—prostate cancer	2.89e-06	2.91e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—SLC5A5—prostate cancer	2.89e-06	2.9e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGFR2—prostate cancer	2.89e-06	2.9e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—COMT—prostate cancer	2.88e-06	2.89e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP1B1—prostate cancer	2.87e-06	2.88e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTP1—prostate cancer	2.86e-06	2.88e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PTEN—prostate cancer	2.85e-06	2.86e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HSD3B1—prostate cancer	2.84e-06	2.86e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC22A3—prostate cancer	2.84e-06	2.86e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP2E1—prostate cancer	2.82e-06	2.83e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ITPR1—prostate cancer	2.82e-06	2.83e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GGT1—prostate cancer	2.81e-06	2.82e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NQO1—prostate cancer	2.79e-06	2.8e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MTHFR—prostate cancer	2.78e-06	2.79e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GGT1—prostate cancer	2.78e-06	2.79e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.77e-06	2.79e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TERT—prostate cancer	2.77e-06	2.79e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NCOA1—prostate cancer	2.76e-06	2.78e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	2.75e-06	2.77e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TH—prostate cancer	2.75e-06	2.76e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	2.74e-06	2.76e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CAV1—prostate cancer	2.74e-06	2.75e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NCOA1—prostate cancer	2.74e-06	2.75e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTA4—prostate cancer	2.73e-06	2.74e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TBXAS1—prostate cancer	2.73e-06	2.74e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP19A1—prostate cancer	2.72e-06	2.74e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP3A4—prostate cancer	2.72e-06	2.73e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CG—prostate cancer	2.71e-06	2.73e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—EP300—prostate cancer	2.71e-06	2.73e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CA—prostate cancer	2.7e-06	2.72e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP19A1—prostate cancer	2.7e-06	2.71e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	2.69e-06	2.71e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP1B1—prostate cancer	2.67e-06	2.69e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—TYMS—prostate cancer	2.66e-06	2.68e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTA2—prostate cancer	2.66e-06	2.67e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HIF1A—prostate cancer	2.65e-06	2.66e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—GSTM1—prostate cancer	2.63e-06	2.65e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—RXRA—prostate cancer	2.63e-06	2.64e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SULT1A1—prostate cancer	2.62e-06	2.64e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ABCG5—prostate cancer	2.62e-06	2.64e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.62e-06	2.63e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—prostate cancer	2.61e-06	2.63e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—RXRA—prostate cancer	2.6e-06	2.62e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GGT1—prostate cancer	2.59e-06	2.6e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—LPL—prostate cancer	2.58e-06	2.6e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—INS—prostate cancer	2.57e-06	2.58e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTA1—prostate cancer	2.56e-06	2.58e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CAV1—prostate cancer	2.56e-06	2.58e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NCOA1—prostate cancer	2.55e-06	2.56e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	2.54e-06	2.56e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTO1—prostate cancer	2.54e-06	2.55e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HSD3B2—prostate cancer	2.54e-06	2.55e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NAT2—prostate cancer	2.54e-06	2.55e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—COMT—prostate cancer	2.53e-06	2.55e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTP1—prostate cancer	2.52e-06	2.53e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CREBBP—prostate cancer	2.52e-06	2.53e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP19A1—prostate cancer	2.51e-06	2.53e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—COMT—prostate cancer	2.51e-06	2.52e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP1A1—prostate cancer	2.5e-06	2.51e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTP1—prostate cancer	2.49e-06	2.51e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CG—prostate cancer	2.49e-06	2.51e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ITPR1—prostate cancer	2.48e-06	2.49e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ERCC2—prostate cancer	2.47e-06	2.49e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ITPR1—prostate cancer	2.45e-06	2.47e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PLCB2—prostate cancer	2.43e-06	2.44e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2C18—prostate cancer	2.43e-06	2.44e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LRP2—prostate cancer	2.43e-06	2.44e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—RXRA—prostate cancer	2.42e-06	2.44e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—BAD—prostate cancer	2.41e-06	2.42e-05	CbGpPWpGaD
Lamivudine—NME1—Metabolism—AKT1—prostate cancer	2.39e-06	2.4e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CD—prostate cancer	2.39e-06	2.4e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—P4HB—prostate cancer	2.38e-06	2.4e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—INS—prostate cancer	2.36e-06	2.37e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—TYMS—prostate cancer	2.34e-06	2.36e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—COMT—prostate cancer	2.34e-06	2.35e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	2.34e-06	2.35e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APC—prostate cancer	2.33e-06	2.35e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—MTHFR—prostate cancer	2.33e-06	2.34e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTP1—prostate cancer	2.32e-06	2.34e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC22A1—prostate cancer	2.32e-06	2.33e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—TYMS—prostate cancer	2.32e-06	2.33e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	2.32e-06	2.33e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—GSTM1—prostate cancer	2.32e-06	2.33e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CREBBP—prostate cancer	2.31e-06	2.33e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGF—prostate cancer	2.31e-06	2.32e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IRS1—prostate cancer	2.31e-06	2.32e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—GSTM1—prostate cancer	2.29e-06	2.3e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ITPR1—prostate cancer	2.29e-06	2.3e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PPARA—prostate cancer	2.28e-06	2.29e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—LPL—prostate cancer	2.27e-06	2.29e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SULT2A1—prostate cancer	2.26e-06	2.27e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	2.26e-06	2.27e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—NOS3—prostate cancer	2.25e-06	2.27e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—LPL—prostate cancer	2.25e-06	2.26e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—GSK3B—prostate cancer	2.24e-06	2.25e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MED12—prostate cancer	2.22e-06	2.24e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—INS—prostate cancer	2.21e-06	2.22e-05	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—AKT1—prostate cancer	2.21e-06	2.22e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GNG5—prostate cancer	2.21e-06	2.22e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP1A1—prostate cancer	2.2e-06	2.21e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CD—prostate cancer	2.19e-06	2.2e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ERCC2—prostate cancer	2.18e-06	2.19e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP1A1—prostate cancer	2.17e-06	2.18e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CREBBP—prostate cancer	2.16e-06	2.18e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—TYMS—prostate cancer	2.16e-06	2.17e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ERCC2—prostate cancer	2.15e-06	2.17e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CAV1—prostate cancer	2.15e-06	2.16e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—GSTM1—prostate cancer	2.14e-06	2.15e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NCOA3—prostate cancer	2.12e-06	2.14e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—LPL—prostate cancer	2.1e-06	2.11e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CB—prostate cancer	2.08e-06	2.09e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—NOS3—prostate cancer	2.07e-06	2.08e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MAP2K1—prostate cancer	2.07e-06	2.08e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTGS2—prostate cancer	2.06e-06	2.07e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CD—prostate cancer	2.05e-06	2.06e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.05e-06	2.06e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—MTHFR—prostate cancer	2.05e-06	2.06e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SERPINE1—prostate cancer	2.03e-06	2.04e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—HPGDS—prostate cancer	2.03e-06	2.04e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—MTHFR—prostate cancer	2.03e-06	2.04e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP1A1—prostate cancer	2.03e-06	2.04e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2C19—prostate cancer	2.01e-06	2.03e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ERCC2—prostate cancer	2.01e-06	2.02e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PPARA—prostate cancer	2.01e-06	2.02e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CA—prostate cancer	2.01e-06	2.02e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PPARA—prostate cancer	1.99e-06	2e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ACHE—prostate cancer	1.97e-06	1.98e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTT1—prostate cancer	1.97e-06	1.98e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—FGF2—prostate cancer	1.96e-06	1.98e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CG—prostate cancer	1.95e-06	1.97e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2A6—prostate cancer	1.94e-06	1.95e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—NOS3—prostate cancer	1.94e-06	1.95e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CB—prostate cancer	1.91e-06	1.92e-05	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	1.91e-06	1.92e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTGS2—prostate cancer	1.89e-06	1.9e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKR1C3—prostate cancer	1.89e-06	1.9e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—MTHFR—prostate cancer	1.89e-06	1.9e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CAV1—prostate cancer	1.89e-06	1.9e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—JAK2—prostate cancer	1.88e-06	1.89e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PRKACB—prostate cancer	1.88e-06	1.89e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CAV1—prostate cancer	1.87e-06	1.88e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP17A1—prostate cancer	1.86e-06	1.87e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PPARA—prostate cancer	1.85e-06	1.86e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—INS—prostate cancer	1.85e-06	1.86e-05	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.84e-06	1.85e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MDM2—prostate cancer	1.84e-06	1.85e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CREBBP—prostate cancer	1.81e-06	1.82e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB2—prostate cancer	1.81e-06	1.82e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PTEN—prostate cancer	1.8e-06	1.81e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CB—prostate cancer	1.79e-06	1.8e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NCOA2—prostate cancer	1.77e-06	1.78e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTGS2—prostate cancer	1.77e-06	1.78e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CAV1—prostate cancer	1.74e-06	1.75e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CG—prostate cancer	1.72e-06	1.73e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CD—prostate cancer	1.72e-06	1.73e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—EP300—prostate cancer	1.71e-06	1.72e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CG—prostate cancer	1.7e-06	1.71e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—SLC5A5—prostate cancer	1.69e-06	1.7e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1B—prostate cancer	1.68e-06	1.69e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2E1—prostate cancer	1.65e-06	1.66e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PTEN—prostate cancer	1.65e-06	1.66e-05	CbGpPWpGaD
Lamivudine—DCK—Metabolism—AKT1—prostate cancer	1.64e-06	1.65e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NQO1—prostate cancer	1.63e-06	1.64e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—INS—prostate cancer	1.63e-06	1.64e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—NOS3—prostate cancer	1.62e-06	1.63e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—INS—prostate cancer	1.61e-06	1.62e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TH—prostate cancer	1.61e-06	1.62e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CREBBP—prostate cancer	1.59e-06	1.6e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP3A4—prostate cancer	1.59e-06	1.6e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CG—prostate cancer	1.59e-06	1.6e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CTNNB1—prostate cancer	1.59e-06	1.59e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CREBBP—prostate cancer	1.58e-06	1.59e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—EP300—prostate cancer	1.57e-06	1.58e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP1B1—prostate cancer	1.57e-06	1.58e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CDKN1A—prostate cancer	1.55e-06	1.56e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PTEN—prostate cancer	1.55e-06	1.55e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GGT1—prostate cancer	1.52e-06	1.53e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CD—prostate cancer	1.51e-06	1.52e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—INS—prostate cancer	1.5e-06	1.51e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CB—prostate cancer	1.5e-06	1.51e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CD—prostate cancer	1.5e-06	1.5e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NCOA1—prostate cancer	1.49e-06	1.5e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTGS2—prostate cancer	1.48e-06	1.49e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EP300—prostate cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP19A1—prostate cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CREBBP—prostate cancer	1.47e-06	1.48e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SRC—prostate cancer	1.43e-06	1.44e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—NOS3—prostate cancer	1.43e-06	1.44e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—RXRA—prostate cancer	1.42e-06	1.43e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—NOS3—prostate cancer	1.41e-06	1.42e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CD—prostate cancer	1.39e-06	1.4e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT3—prostate cancer	1.38e-06	1.39e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—COMT—prostate cancer	1.37e-06	1.38e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTP1—prostate cancer	1.36e-06	1.37e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ITPR1—prostate cancer	1.34e-06	1.35e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CB—prostate cancer	1.32e-06	1.33e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—NOS3—prostate cancer	1.32e-06	1.32e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTGS2—prostate cancer	1.31e-06	1.31e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CB—prostate cancer	1.3e-06	1.31e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PTEN—prostate cancer	1.29e-06	1.3e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTGS2—prostate cancer	1.29e-06	1.3e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—prostate cancer	1.28e-06	1.29e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—TGFB1—prostate cancer	1.28e-06	1.29e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CA—prostate cancer	1.27e-06	1.27e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—TYMS—prostate cancer	1.27e-06	1.27e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—prostate cancer	1.26e-06	1.26e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—GSTM1—prostate cancer	1.25e-06	1.26e-05	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—EP300—prostate cancer	1.23e-06	1.24e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—LPL—prostate cancer	1.23e-06	1.24e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CB—prostate cancer	1.22e-06	1.22e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTGS2—prostate cancer	1.2e-06	1.21e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP1A1—prostate cancer	1.19e-06	1.19e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—KRAS—prostate cancer	1.19e-06	1.19e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ERCC2—prostate cancer	1.18e-06	1.18e-05	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CA—prostate cancer	1.17e-06	1.17e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PTEN—prostate cancer	1.14e-06	1.15e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PTEN—prostate cancer	1.13e-06	1.13e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—MTHFR—prostate cancer	1.11e-06	1.11e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PIK3CA—prostate cancer	1.09e-06	1.1e-05	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—EP300—prostate cancer	1.09e-06	1.09e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PPARA—prostate cancer	1.09e-06	1.09e-05	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—EP300—prostate cancer	1.07e-06	1.08e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PTEN—prostate cancer	1.05e-06	1.06e-05	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—AKT1—prostate cancer	1.04e-06	1.04e-05	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CAV1—prostate cancer	1.02e-06	1.03e-05	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—EP300—prostate cancer	1e-06	1.01e-05	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IL6—prostate cancer	9.65e-07	9.71e-06	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—AKT1—prostate cancer	9.52e-07	9.57e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CG—prostate cancer	9.3e-07	9.35e-06	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CA—prostate cancer	9.13e-07	9.18e-06	CbGpPWpGaD
Lamivudine—ABCC1—Disease—AKT1—prostate cancer	8.9e-07	8.95e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—INS—prostate cancer	8.8e-07	8.85e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CREBBP—prostate cancer	8.62e-07	8.67e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CD—prostate cancer	8.17e-07	8.22e-06	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CA—prostate cancer	8.03e-07	8.08e-06	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CA—prostate cancer	7.95e-07	7.99e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—NOS3—prostate cancer	7.72e-07	7.76e-06	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—AKT1—prostate cancer	7.46e-07	7.5e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CA—prostate cancer	7.41e-07	7.45e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CB—prostate cancer	7.12e-07	7.16e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTGS2—prostate cancer	7.06e-07	7.1e-06	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—AKT1—prostate cancer	6.56e-07	6.6e-06	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—AKT1—prostate cancer	6.49e-07	6.53e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PTEN—prostate cancer	6.16e-07	6.19e-06	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—AKT1—prostate cancer	6.05e-07	6.09e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—EP300—prostate cancer	5.87e-07	5.9e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CA—prostate cancer	4.34e-07	4.37e-06	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—AKT1—prostate cancer	3.55e-07	3.57e-06	CbGpPWpGaD
